Recruiting

Care Coordination

Sponsor:

UCLA

Code:

NCT07106151

Conditions

AKI

AKI - Acute Kidney Injury

Dialysis Patients

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Transmission of additional AKI-D recovery information

No additional AKI-D recovery information

Study Details

Brief summary:

Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at the time of discharge and communicating that result to the accepting nephrologist and the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.

Conditions

AKI

AKI - Acute Kidney Injury

Dialysis Patients

Study ID

NCT07106151

Start date

Feb 23, 2026

Status verified date

Feb, 2026

Completion date

Jan, 2028

Anticipated

Primary completion date

Jan, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • AKI-D (not ESKD, as determined by the clinical inpatient nephrology team)
  • Age ≥ 18 years
  • Planned for continued dialysis outside the acute hospital setting (at outpatient dialysis unit/SNF/LTACH, not planned transfer to another short-stay acute care hospital).

Exclusion Criteria:

  • Pregnant
  • Prisoner
  • Unable to consent and no surrogate decision maker available
  • Clinical team declines to allow approach for study

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Additional AKI-D recovery information

active comparator: No additional AKI-D recovery information

Interventions

Transmission of additional AKI-D recovery information

Measuring residual kidney function at the time of hospital discharge by timed urine collection (6-24 hours in duration), transmitting the results (urine volume, urea clearance, and creatinine clearance) to the accepting nephrologist and to the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.

No additional AKI-D recovery information

The same timed urine collection will be collected at the time of hospital discharge as in the intervention arm, but in the control arm the results will not be transmitted to the accepting nephrologist or to the patient and no information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule will be transmitted. Instead, the research team will call the accepting nephrologist to alert them that this is an AKI-D patient that is being followed by the research team for recovery for up to 60 days.

Primary outcome measure

  • Feasibility: The proportion of patients who complete the timed urine collection within seven days before discharge and are able to have the results successfully transmitted to the accepting nephrologist and patient. [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Ian E McCoy, MD, MS

415-353-2507ian.mccoy@ucsf.edu

Locations

University of California, San Francisco

Recruiting

San Francisco, California, United States, 94143

More Information

Sponsor

University of California, San Francisco

Last update posted

Feb 27, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-02-27.